These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30707225)

  • 1. Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial.
    Cartwright RD; Crowther CA; Anderson PJ; Harding JE; Doyle LW; McKinlay CJD
    JAMA Netw Open; 2019 Feb; 2(2):e187636. PubMed ID: 30707225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Antenatal Betamethasone and Cardiometabolic Outcomes.
    Cartwright RD; Harding JE; Crowther CA; Cutfield WS; Battin MR; Dalziel SR; McKinlay CJD;
    Pediatrics; 2018 Jul; 142(1):. PubMed ID: 29895522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5).
    Asztalos EV; Murphy KE; Willan AR; Matthews SG; Ohlsson A; Saigal S; Armson BA; Kelly EN; Delisle MF; Gafni A; Lee SK; Sananes R; Rovet J; Guselle P; Amankwah K; Saleem M; Sanchez J;
    JAMA Pediatr; 2013 Dec; 167(12):1102-10. PubMed ID: 24126948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-Childhood Outcomes of Repeat Antenatal Corticosteroids: A Randomized Controlled Trial.
    Crowther CA; Anderson PJ; McKinlay CJ; Harding JE; Ashwood PJ; Haslam RR; Robinson JS; Doyle LW;
    Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27650051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study.
    Gyamfi-Bannerman C; Clifton RG; Tita ATN; Blackwell SC; Longo M; de Voest JA; O'Shea TM; Bousleiman SZ; Ortiz F; Rouse DJ; Metz TD; Saade GR; Rood KM; Heyborne KD; Thorp JM; Swamy GK; Grobman WA; Gibson KS; El-Sayed YY; Macones GA;
    JAMA; 2024 May; 331(19):1629-1637. PubMed ID: 38656759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-Childhood Bone Mass After Exposure to Repeat Doses of Antenatal Glucocorticoids: A Randomized Trial.
    McKinlay CJD; Cutfield WS; Battin MR; Dalziel SR; Crowther CA; Harding JE;
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial.
    Crowther CA; Ashwood P; Andersen CC; Middleton PF; Tran T; Doyle LW; Robinson JS; Harding JE;
    Lancet Child Adolesc Health; 2019 Nov; 3(11):769-780. PubMed ID: 31523039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol.
    Crowther CA; Harding JE; Middleton PF; Andersen CC; Ashwood P; Robinson JS;
    BMC Pregnancy Childbirth; 2013 May; 13():104. PubMed ID: 23642125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
    Peltoniemi OM; Kari MA; Lano A; Yliherva A; Puosi R; Lehtonen L; Tammela O; Hallman M;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F402-6. PubMed ID: 19531521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial.
    Hofer OJ; Harding JE; Tran T; Crowther CA
    PLoS One; 2022; 17(2):e0263927. PubMed ID: 35192656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after repeat doses of antenatal corticosteroids.
    Wapner RJ; Sorokin Y; Mele L; Johnson F; Dudley DJ; Spong CY; Peaceman AM; Leveno KJ; Malone F; Caritis SN; Mercer B; Harper M; Rouse DJ; Thorp JM; Ramin S; Carpenter MW; Gabbe SG;
    N Engl J Med; 2007 Sep; 357(12):1190-8. PubMed ID: 17881751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial.
    Gyamfi-Bannerman C; Zupancic JAF; Sandoval G; Grobman WA; Blackwell SC; Tita ATN; Reddy UM; Jain L; Saade GR; Rouse DJ; Iams JD; Clark EAS; Thorp JM; Chien EK; Peaceman AM; Gibbs RS; Swamy GK; Norton ME; Casey BM; Caritis SN; Tolosa JE; Sorokin Y; VanDorsten JP;
    JAMA Pediatr; 2019 May; 173(5):462-468. PubMed ID: 30855640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.
    Crowther CA; Haslam RR; Hiller JE; Doyle LW; Robinson JS;
    Lancet; 2006 Jun; 367(9526):1913-9. PubMed ID: 16765760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: an RCT.
    McKinlay CJ; Cutfield WS; Battin MR; Dalziel SR; Crowther CA; Harding JE;
    Pediatrics; 2015 Feb; 135(2):e405-15. PubMed ID: 25601978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival without severe neonatal morbidity after antenatal betamethasone dose reduction: a post hoc analysis of a randomized non-inferiority trial.
    Baud O; Sentilhes L; Ursino M; Doret-Dion M; Alberti C; Aupiais C; Schmitz T;
    Am J Obstet Gynecol; 2024 Oct; 231(4):458.e1-458.e16. PubMed ID: 38341166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial.
    Guinn DA; Atkinson MW; Sullivan L; Lee M; MacGregor S; Parilla BV; Davies J; Hanlon-Lundberg K; Simpson L; Stone J; Wing D; Ogasawara K; Muraskas J
    JAMA; 2001 Oct; 286(13):1581-7. PubMed ID: 11585480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.
    Williams MJ; Ramson JA; Brownfoot FC
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006764. PubMed ID: 35943347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Booster course of antenatal corticosteroids after preterm prelabor rupture of membranes: a double-blind randomized trial.
    Porreco R; Garite TJ; Combs CA; Maurel K; Huls CK; Baker S; Fortner KB; Longo SA; Nageotte M; Lewis D; Tran L;
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100896. PubMed ID: 36796641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth restricting effects of a single course of antenatal betamethasone treatment and the role of human placental lactogen.
    Braun T; Husar A; Challis JR; Dudenhausen JW; Henrich W; Plagemann A; Sloboda DM
    Placenta; 2013 May; 34(5):407-15. PubMed ID: 23465880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.